Global On-body Injectors Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global On-body Injectors market size was valued at USD 148.2 million in 2022 and is forecast to a readjusted size of USD 378.9 million by 2029 with a CAGR of 14.4% during review period.
On-body injectors, also known as on-body delivery systems (OBDS), are medical devices designed to deliver a controlled dose of medication or therapeutic substances subcutaneously (under the skin) over a specified period. These devices are typically worn on the body and are used to administer various treatments, including medications, hormones, and biologics. On-body injectors offer several advantages, including increased patient convenience, improved medication adherence, and the ability to deliver complex therapies.
The scope of this report is non-insulin On-body injectors.
In the global market, On-body Injectors is dominated by core players such as AWest Pharmaceutical Services, Insulet, Gerresheimer, ect. The top three players within this industry account for about 80% of the market share. North America, Europe, and Asia-Pacific are the major manufacturing regions for this product, and they all hold about 15% of the global market share. The product can be categorised on the basis of product type into electronic syringes and mechanical syringes. The product is widely used in the treatment of oncology immunology, cardiovascular diseases, neurological disorders, and other diseases.
The Global Info Research report includes an overview of the development of the On-body Injectors industry chain, the market status of Immuno-oncology (Electronic Injectors, Mechanical Injectors), Cardiovascular Diseases (Electronic Injectors, Mechanical Injectors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of On-body Injectors.
Regionally, the report analyzes the On-body Injectors markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global On-body Injectors market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the On-body Injectors market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the On-body Injectors industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Electronic Injectors, Mechanical Injectors).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the On-body Injectors market.
Regional Analysis: The report involves examining the On-body Injectors market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the On-body Injectors market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to On-body Injectors:
Company Analysis: Report covers individual On-body Injectors manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards On-body Injectors This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Immuno-oncology, Cardiovascular Diseases).
Technology Analysis: Report covers specific technologies relevant to On-body Injectors. It assesses the current state, advancements, and potential future developments in On-body Injectors areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the On-body Injectors market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
On-body Injectors market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe On-body Injectors product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of On-body Injectors, with price, sales, revenue and global market share of On-body Injectors from 2018 to 2023.
Chapter 3, the On-body Injectors competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the On-body Injectors breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and On-body Injectors market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of On-body Injectors.
Chapter 14 and 15, to describe On-body Injectors sales channel, distributors, customers, research findings and conclusion.
On-body injectors, also known as on-body delivery systems (OBDS), are medical devices designed to deliver a controlled dose of medication or therapeutic substances subcutaneously (under the skin) over a specified period. These devices are typically worn on the body and are used to administer various treatments, including medications, hormones, and biologics. On-body injectors offer several advantages, including increased patient convenience, improved medication adherence, and the ability to deliver complex therapies.
The scope of this report is non-insulin On-body injectors.
In the global market, On-body Injectors is dominated by core players such as AWest Pharmaceutical Services, Insulet, Gerresheimer, ect. The top three players within this industry account for about 80% of the market share. North America, Europe, and Asia-Pacific are the major manufacturing regions for this product, and they all hold about 15% of the global market share. The product can be categorised on the basis of product type into electronic syringes and mechanical syringes. The product is widely used in the treatment of oncology immunology, cardiovascular diseases, neurological disorders, and other diseases.
The Global Info Research report includes an overview of the development of the On-body Injectors industry chain, the market status of Immuno-oncology (Electronic Injectors, Mechanical Injectors), Cardiovascular Diseases (Electronic Injectors, Mechanical Injectors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of On-body Injectors.
Regionally, the report analyzes the On-body Injectors markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global On-body Injectors market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the On-body Injectors market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the On-body Injectors industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Electronic Injectors, Mechanical Injectors).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the On-body Injectors market.
Regional Analysis: The report involves examining the On-body Injectors market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the On-body Injectors market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to On-body Injectors:
Company Analysis: Report covers individual On-body Injectors manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards On-body Injectors This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Immuno-oncology, Cardiovascular Diseases).
Technology Analysis: Report covers specific technologies relevant to On-body Injectors. It assesses the current state, advancements, and potential future developments in On-body Injectors areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the On-body Injectors market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
On-body Injectors market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Electronic Injectors
- Mechanical Injectors
- Immuno-oncology
- Cardiovascular Diseases
- Neurological Diseases
- Others
- West Pharmaceutical Services
- Insulet
- Gerresheimer
- United Therapeutics
- CC Bio
- BD
- Ypsomed
- Enable Injections
- Nemera
- Stevanato Group
- Sonceboz
- Lohmann Therapie-Systeme
- Elcam Drug Delivery Devices (E3D)
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe On-body Injectors product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of On-body Injectors, with price, sales, revenue and global market share of On-body Injectors from 2018 to 2023.
Chapter 3, the On-body Injectors competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the On-body Injectors breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and On-body Injectors market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of On-body Injectors.
Chapter 14 and 15, to describe On-body Injectors sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of On-body Injectors
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global On-body Injectors Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Electronic Injectors
1.3.3 Mechanical Injectors
1.4 Market Analysis by Application
1.4.1 Overview: Global On-body Injectors Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Immuno-oncology
1.4.3 Cardiovascular Diseases
1.4.4 Neurological Diseases
1.4.5 Others
1.5 Global On-body Injectors Market Size & Forecast
1.5.1 Global On-body Injectors Consumption Value (2018 & 2022 & 2029)
1.5.2 Global On-body Injectors Sales Quantity (2018-2029)
1.5.3 Global On-body Injectors Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 West Pharmaceutical Services
2.1.1 West Pharmaceutical Services Details
2.1.2 West Pharmaceutical Services Major Business
2.1.3 West Pharmaceutical Services On-body Injectors Product and Services
2.1.4 West Pharmaceutical Services On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 West Pharmaceutical Services Recent Developments/Updates
2.2 Insulet
2.2.1 Insulet Details
2.2.2 Insulet Major Business
2.2.3 Insulet On-body Injectors Product and Services
2.2.4 Insulet On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Insulet Recent Developments/Updates
2.3 Gerresheimer
2.3.1 Gerresheimer Details
2.3.2 Gerresheimer Major Business
2.3.3 Gerresheimer On-body Injectors Product and Services
2.3.4 Gerresheimer On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Gerresheimer Recent Developments/Updates
2.4 United Therapeutics
2.4.1 United Therapeutics Details
2.4.2 United Therapeutics Major Business
2.4.3 United Therapeutics On-body Injectors Product and Services
2.4.4 United Therapeutics On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 United Therapeutics Recent Developments/Updates
2.5 CC Bio
2.5.1 CC Bio Details
2.5.2 CC Bio Major Business
2.5.3 CC Bio On-body Injectors Product and Services
2.5.4 CC Bio On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 CC Bio Recent Developments/Updates
2.6 BD
2.6.1 BD Details
2.6.2 BD Major Business
2.6.3 BD On-body Injectors Product and Services
2.6.4 BD On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 BD Recent Developments/Updates
2.7 Ypsomed
2.7.1 Ypsomed Details
2.7.2 Ypsomed Major Business
2.7.3 Ypsomed On-body Injectors Product and Services
2.7.4 Ypsomed On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Ypsomed Recent Developments/Updates
2.8 Enable Injections
2.8.1 Enable Injections Details
2.8.2 Enable Injections Major Business
2.8.3 Enable Injections On-body Injectors Product and Services
2.8.4 Enable Injections On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Enable Injections Recent Developments/Updates
2.9 Nemera
2.9.1 Nemera Details
2.9.2 Nemera Major Business
2.9.3 Nemera On-body Injectors Product and Services
2.9.4 Nemera On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Nemera Recent Developments/Updates
2.10 Stevanato Group
2.10.1 Stevanato Group Details
2.10.2 Stevanato Group Major Business
2.10.3 Stevanato Group On-body Injectors Product and Services
2.10.4 Stevanato Group On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Stevanato Group Recent Developments/Updates
2.11 Sonceboz
2.11.1 Sonceboz Details
2.11.2 Sonceboz Major Business
2.11.3 Sonceboz On-body Injectors Product and Services
2.11.4 Sonceboz On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Sonceboz Recent Developments/Updates
2.12 Lohmann Therapie-Systeme
2.12.1 Lohmann Therapie-Systeme Details
2.12.2 Lohmann Therapie-Systeme Major Business
2.12.3 Lohmann Therapie-Systeme On-body Injectors Product and Services
2.12.4 Lohmann Therapie-Systeme On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Lohmann Therapie-Systeme Recent Developments/Updates
2.13 Elcam Drug Delivery Devices (E3D)
2.13.1 Elcam Drug Delivery Devices (E3D) Details
2.13.2 Elcam Drug Delivery Devices (E3D) Major Business
2.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Product and Services
2.13.4 Elcam Drug Delivery Devices (E3D) On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Elcam Drug Delivery Devices (E3D) Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ON-BODY INJECTORS BY MANUFACTURER
3.1 Global On-body Injectors Sales Quantity by Manufacturer (2018-2023)
3.2 Global On-body Injectors Revenue by Manufacturer (2018-2023)
3.3 Global On-body Injectors Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of On-body Injectors by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 On-body Injectors Manufacturer Market Share in 2022
3.4.2 Top 6 On-body Injectors Manufacturer Market Share in 2022
3.5 On-body Injectors Market: Overall Company Footprint Analysis
3.5.1 On-body Injectors Market: Region Footprint
3.5.2 On-body Injectors Market: Company Product Type Footprint
3.5.3 On-body Injectors Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global On-body Injectors Market Size by Region
4.1.1 Global On-body Injectors Sales Quantity by Region (2018-2029)
4.1.2 Global On-body Injectors Consumption Value by Region (2018-2029)
4.1.3 Global On-body Injectors Average Price by Region (2018-2029)
4.2 North America On-body Injectors Consumption Value (2018-2029)
4.3 Europe On-body Injectors Consumption Value (2018-2029)
4.4 Asia-Pacific On-body Injectors Consumption Value (2018-2029)
4.5 South America On-body Injectors Consumption Value (2018-2029)
4.6 Middle East and Africa On-body Injectors Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global On-body Injectors Sales Quantity by Type (2018-2029)
5.2 Global On-body Injectors Consumption Value by Type (2018-2029)
5.3 Global On-body Injectors Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global On-body Injectors Sales Quantity by Application (2018-2029)
6.2 Global On-body Injectors Consumption Value by Application (2018-2029)
6.3 Global On-body Injectors Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America On-body Injectors Sales Quantity by Type (2018-2029)
7.2 North America On-body Injectors Sales Quantity by Application (2018-2029)
7.3 North America On-body Injectors Market Size by Country
7.3.1 North America On-body Injectors Sales Quantity by Country (2018-2029)
7.3.2 North America On-body Injectors Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe On-body Injectors Sales Quantity by Type (2018-2029)
8.2 Europe On-body Injectors Sales Quantity by Application (2018-2029)
8.3 Europe On-body Injectors Market Size by Country
8.3.1 Europe On-body Injectors Sales Quantity by Country (2018-2029)
8.3.2 Europe On-body Injectors Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific On-body Injectors Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific On-body Injectors Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific On-body Injectors Market Size by Region
9.3.1 Asia-Pacific On-body Injectors Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific On-body Injectors Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America On-body Injectors Sales Quantity by Type (2018-2029)
10.2 South America On-body Injectors Sales Quantity by Application (2018-2029)
10.3 South America On-body Injectors Market Size by Country
10.3.1 South America On-body Injectors Sales Quantity by Country (2018-2029)
10.3.2 South America On-body Injectors Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa On-body Injectors Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa On-body Injectors Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa On-body Injectors Market Size by Country
11.3.1 Middle East & Africa On-body Injectors Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa On-body Injectors Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 On-body Injectors Market Drivers
12.2 On-body Injectors Market Restraints
12.3 On-body Injectors Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of On-body Injectors and Key Manufacturers
13.2 Manufacturing Costs Percentage of On-body Injectors
13.3 On-body Injectors Production Process
13.4 On-body Injectors Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 On-body Injectors Typical Distributors
14.3 On-body Injectors Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of On-body Injectors
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global On-body Injectors Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Electronic Injectors
1.3.3 Mechanical Injectors
1.4 Market Analysis by Application
1.4.1 Overview: Global On-body Injectors Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Immuno-oncology
1.4.3 Cardiovascular Diseases
1.4.4 Neurological Diseases
1.4.5 Others
1.5 Global On-body Injectors Market Size & Forecast
1.5.1 Global On-body Injectors Consumption Value (2018 & 2022 & 2029)
1.5.2 Global On-body Injectors Sales Quantity (2018-2029)
1.5.3 Global On-body Injectors Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 West Pharmaceutical Services
2.1.1 West Pharmaceutical Services Details
2.1.2 West Pharmaceutical Services Major Business
2.1.3 West Pharmaceutical Services On-body Injectors Product and Services
2.1.4 West Pharmaceutical Services On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 West Pharmaceutical Services Recent Developments/Updates
2.2 Insulet
2.2.1 Insulet Details
2.2.2 Insulet Major Business
2.2.3 Insulet On-body Injectors Product and Services
2.2.4 Insulet On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Insulet Recent Developments/Updates
2.3 Gerresheimer
2.3.1 Gerresheimer Details
2.3.2 Gerresheimer Major Business
2.3.3 Gerresheimer On-body Injectors Product and Services
2.3.4 Gerresheimer On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Gerresheimer Recent Developments/Updates
2.4 United Therapeutics
2.4.1 United Therapeutics Details
2.4.2 United Therapeutics Major Business
2.4.3 United Therapeutics On-body Injectors Product and Services
2.4.4 United Therapeutics On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 United Therapeutics Recent Developments/Updates
2.5 CC Bio
2.5.1 CC Bio Details
2.5.2 CC Bio Major Business
2.5.3 CC Bio On-body Injectors Product and Services
2.5.4 CC Bio On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 CC Bio Recent Developments/Updates
2.6 BD
2.6.1 BD Details
2.6.2 BD Major Business
2.6.3 BD On-body Injectors Product and Services
2.6.4 BD On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 BD Recent Developments/Updates
2.7 Ypsomed
2.7.1 Ypsomed Details
2.7.2 Ypsomed Major Business
2.7.3 Ypsomed On-body Injectors Product and Services
2.7.4 Ypsomed On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Ypsomed Recent Developments/Updates
2.8 Enable Injections
2.8.1 Enable Injections Details
2.8.2 Enable Injections Major Business
2.8.3 Enable Injections On-body Injectors Product and Services
2.8.4 Enable Injections On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Enable Injections Recent Developments/Updates
2.9 Nemera
2.9.1 Nemera Details
2.9.2 Nemera Major Business
2.9.3 Nemera On-body Injectors Product and Services
2.9.4 Nemera On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Nemera Recent Developments/Updates
2.10 Stevanato Group
2.10.1 Stevanato Group Details
2.10.2 Stevanato Group Major Business
2.10.3 Stevanato Group On-body Injectors Product and Services
2.10.4 Stevanato Group On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Stevanato Group Recent Developments/Updates
2.11 Sonceboz
2.11.1 Sonceboz Details
2.11.2 Sonceboz Major Business
2.11.3 Sonceboz On-body Injectors Product and Services
2.11.4 Sonceboz On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Sonceboz Recent Developments/Updates
2.12 Lohmann Therapie-Systeme
2.12.1 Lohmann Therapie-Systeme Details
2.12.2 Lohmann Therapie-Systeme Major Business
2.12.3 Lohmann Therapie-Systeme On-body Injectors Product and Services
2.12.4 Lohmann Therapie-Systeme On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Lohmann Therapie-Systeme Recent Developments/Updates
2.13 Elcam Drug Delivery Devices (E3D)
2.13.1 Elcam Drug Delivery Devices (E3D) Details
2.13.2 Elcam Drug Delivery Devices (E3D) Major Business
2.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Product and Services
2.13.4 Elcam Drug Delivery Devices (E3D) On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Elcam Drug Delivery Devices (E3D) Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ON-BODY INJECTORS BY MANUFACTURER
3.1 Global On-body Injectors Sales Quantity by Manufacturer (2018-2023)
3.2 Global On-body Injectors Revenue by Manufacturer (2018-2023)
3.3 Global On-body Injectors Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of On-body Injectors by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 On-body Injectors Manufacturer Market Share in 2022
3.4.2 Top 6 On-body Injectors Manufacturer Market Share in 2022
3.5 On-body Injectors Market: Overall Company Footprint Analysis
3.5.1 On-body Injectors Market: Region Footprint
3.5.2 On-body Injectors Market: Company Product Type Footprint
3.5.3 On-body Injectors Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global On-body Injectors Market Size by Region
4.1.1 Global On-body Injectors Sales Quantity by Region (2018-2029)
4.1.2 Global On-body Injectors Consumption Value by Region (2018-2029)
4.1.3 Global On-body Injectors Average Price by Region (2018-2029)
4.2 North America On-body Injectors Consumption Value (2018-2029)
4.3 Europe On-body Injectors Consumption Value (2018-2029)
4.4 Asia-Pacific On-body Injectors Consumption Value (2018-2029)
4.5 South America On-body Injectors Consumption Value (2018-2029)
4.6 Middle East and Africa On-body Injectors Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global On-body Injectors Sales Quantity by Type (2018-2029)
5.2 Global On-body Injectors Consumption Value by Type (2018-2029)
5.3 Global On-body Injectors Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global On-body Injectors Sales Quantity by Application (2018-2029)
6.2 Global On-body Injectors Consumption Value by Application (2018-2029)
6.3 Global On-body Injectors Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America On-body Injectors Sales Quantity by Type (2018-2029)
7.2 North America On-body Injectors Sales Quantity by Application (2018-2029)
7.3 North America On-body Injectors Market Size by Country
7.3.1 North America On-body Injectors Sales Quantity by Country (2018-2029)
7.3.2 North America On-body Injectors Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe On-body Injectors Sales Quantity by Type (2018-2029)
8.2 Europe On-body Injectors Sales Quantity by Application (2018-2029)
8.3 Europe On-body Injectors Market Size by Country
8.3.1 Europe On-body Injectors Sales Quantity by Country (2018-2029)
8.3.2 Europe On-body Injectors Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific On-body Injectors Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific On-body Injectors Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific On-body Injectors Market Size by Region
9.3.1 Asia-Pacific On-body Injectors Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific On-body Injectors Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America On-body Injectors Sales Quantity by Type (2018-2029)
10.2 South America On-body Injectors Sales Quantity by Application (2018-2029)
10.3 South America On-body Injectors Market Size by Country
10.3.1 South America On-body Injectors Sales Quantity by Country (2018-2029)
10.3.2 South America On-body Injectors Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa On-body Injectors Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa On-body Injectors Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa On-body Injectors Market Size by Country
11.3.1 Middle East & Africa On-body Injectors Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa On-body Injectors Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 On-body Injectors Market Drivers
12.2 On-body Injectors Market Restraints
12.3 On-body Injectors Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of On-body Injectors and Key Manufacturers
13.2 Manufacturing Costs Percentage of On-body Injectors
13.3 On-body Injectors Production Process
13.4 On-body Injectors Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 On-body Injectors Typical Distributors
14.3 On-body Injectors Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global On-body Injectors Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global On-body Injectors Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. West Pharmaceutical Services Basic Information, Manufacturing Base and Competitors
Table 4. West Pharmaceutical Services Major Business
Table 5. West Pharmaceutical Services On-body Injectors Product and Services
Table 6. West Pharmaceutical Services On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. West Pharmaceutical Services Recent Developments/Updates
Table 8. Insulet Basic Information, Manufacturing Base and Competitors
Table 9. Insulet Major Business
Table 10. Insulet On-body Injectors Product and Services
Table 11. Insulet On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Insulet Recent Developments/Updates
Table 13. Gerresheimer Basic Information, Manufacturing Base and Competitors
Table 14. Gerresheimer Major Business
Table 15. Gerresheimer On-body Injectors Product and Services
Table 16. Gerresheimer On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Gerresheimer Recent Developments/Updates
Table 18. United Therapeutics Basic Information, Manufacturing Base and Competitors
Table 19. United Therapeutics Major Business
Table 20. United Therapeutics On-body Injectors Product and Services
Table 21. United Therapeutics On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. United Therapeutics Recent Developments/Updates
Table 23. CC Bio Basic Information, Manufacturing Base and Competitors
Table 24. CC Bio Major Business
Table 25. CC Bio On-body Injectors Product and Services
Table 26. CC Bio On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. CC Bio Recent Developments/Updates
Table 28. BD Basic Information, Manufacturing Base and Competitors
Table 29. BD Major Business
Table 30. BD On-body Injectors Product and Services
Table 31. BD On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. BD Recent Developments/Updates
Table 33. Ypsomed Basic Information, Manufacturing Base and Competitors
Table 34. Ypsomed Major Business
Table 35. Ypsomed On-body Injectors Product and Services
Table 36. Ypsomed On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Ypsomed Recent Developments/Updates
Table 38. Enable Injections Basic Information, Manufacturing Base and Competitors
Table 39. Enable Injections Major Business
Table 40. Enable Injections On-body Injectors Product and Services
Table 41. Enable Injections On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Enable Injections Recent Developments/Updates
Table 43. Nemera Basic Information, Manufacturing Base and Competitors
Table 44. Nemera Major Business
Table 45. Nemera On-body Injectors Product and Services
Table 46. Nemera On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Nemera Recent Developments/Updates
Table 48. Stevanato Group Basic Information, Manufacturing Base and Competitors
Table 49. Stevanato Group Major Business
Table 50. Stevanato Group On-body Injectors Product and Services
Table 51. Stevanato Group On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Stevanato Group Recent Developments/Updates
Table 53. Sonceboz Basic Information, Manufacturing Base and Competitors
Table 54. Sonceboz Major Business
Table 55. Sonceboz On-body Injectors Product and Services
Table 56. Sonceboz On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Sonceboz Recent Developments/Updates
Table 58. Lohmann Therapie-Systeme Basic Information, Manufacturing Base and Competitors
Table 59. Lohmann Therapie-Systeme Major Business
Table 60. Lohmann Therapie-Systeme On-body Injectors Product and Services
Table 61. Lohmann Therapie-Systeme On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Lohmann Therapie-Systeme Recent Developments/Updates
Table 63. Elcam Drug Delivery Devices (E3D) Basic Information, Manufacturing Base and Competitors
Table 64. Elcam Drug Delivery Devices (E3D) Major Business
Table 65. Elcam Drug Delivery Devices (E3D) On-body Injectors Product and Services
Table 66. Elcam Drug Delivery Devices (E3D) On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Elcam Drug Delivery Devices (E3D) Recent Developments/Updates
Table 68. Global On-body Injectors Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 69. Global On-body Injectors Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global On-body Injectors Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 71. Market Position of Manufacturers in On-body Injectors, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and On-body Injectors Production Site of Key Manufacturer
Table 73. On-body Injectors Market: Company Product Type Footprint
Table 74. On-body Injectors Market: Company Product Application Footprint
Table 75. On-body Injectors New Market Entrants and Barriers to Market Entry
Table 76. On-body Injectors Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global On-body Injectors Sales Quantity by Region (2018-2023) & (K Units)
Table 78. Global On-body Injectors Sales Quantity by Region (2024-2029) & (K Units)
Table 79. Global On-body Injectors Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global On-body Injectors Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global On-body Injectors Average Price by Region (2018-2023) & (US$/Unit)
Table 82. Global On-body Injectors Average Price by Region (2024-2029) & (US$/Unit)
Table 83. Global On-body Injectors Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Global On-body Injectors Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Global On-body Injectors Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global On-body Injectors Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global On-body Injectors Average Price by Type (2018-2023) & (US$/Unit)
Table 88. Global On-body Injectors Average Price by Type (2024-2029) & (US$/Unit)
Table 89. Global On-body Injectors Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Global On-body Injectors Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Global On-body Injectors Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global On-body Injectors Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global On-body Injectors Average Price by Application (2018-2023) & (US$/Unit)
Table 94. Global On-body Injectors Average Price by Application (2024-2029) & (US$/Unit)
Table 95. North America On-body Injectors Sales Quantity by Type (2018-2023) & (K Units)
Table 96. North America On-body Injectors Sales Quantity by Type (2024-2029) & (K Units)
Table 97. North America On-body Injectors Sales Quantity by Application (2018-2023) & (K Units)
Table 98. North America On-body Injectors Sales Quantity by Application (2024-2029) & (K Units)
Table 99. North America On-body Injectors Sales Quantity by Country (2018-2023) & (K Units)
Table 100. North America On-body Injectors Sales Quantity by Country (2024-2029) & (K Units)
Table 101. North America On-body Injectors Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America On-body Injectors Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe On-body Injectors Sales Quantity by Type (2018-2023) & (K Units)
Table 104. Europe On-body Injectors Sales Quantity by Type (2024-2029) & (K Units)
Table 105. Europe On-body Injectors Sales Quantity by Application (2018-2023) & (K Units)
Table 106. Europe On-body Injectors Sales Quantity by Application (2024-2029) & (K Units)
Table 107. Europe On-body Injectors Sales Quantity by Country (2018-2023) & (K Units)
Table 108. Europe On-body Injectors Sales Quantity by Country (2024-2029) & (K Units)
Table 109. Europe On-body Injectors Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe On-body Injectors Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific On-body Injectors Sales Quantity by Type (2018-2023) & (K Units)
Table 112. Asia-Pacific On-body Injectors Sales Quantity by Type (2024-2029) & (K Units)
Table 113. Asia-Pacific On-body Injectors Sales Quantity by Application (2018-2023) & (K Units)
Table 114. Asia-Pacific On-body Injectors Sales Quantity by Application (2024-2029) & (K Units)
Table 115. Asia-Pacific On-body Injectors Sales Quantity by Region (2018-2023) & (K Units)
Table 116. Asia-Pacific On-body Injectors Sales Quantity by Region (2024-2029) & (K Units)
Table 117. Asia-Pacific On-body Injectors Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific On-body Injectors Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America On-body Injectors Sales Quantity by Type (2018-2023) & (K Units)
Table 120. South America On-body Injectors Sales Quantity by Type (2024-2029) & (K Units)
Table 121. South America On-body Injectors Sales Quantity by Application (2018-2023) & (K Units)
Table 122. South America On-body Injectors Sales Quantity by Application (2024-2029) & (K Units)
Table 123. South America On-body Injectors Sales Quantity by Country (2018-2023) & (K Units)
Table 124. South America On-body Injectors Sales Quantity by Country (2024-2029) & (K Units)
Table 125. South America On-body Injectors Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America On-body Injectors Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa On-body Injectors Sales Quantity by Type (2018-2023) & (K Units)
Table 128. Middle East & Africa On-body Injectors Sales Quantity by Type (2024-2029) & (K Units)
Table 129. Middle East & Africa On-body Injectors Sales Quantity by Application (2018-2023) & (K Units)
Table 130. Middle East & Africa On-body Injectors Sales Quantity by Application (2024-2029) & (K Units)
Table 131. Middle East & Africa On-body Injectors Sales Quantity by Region (2018-2023) & (K Units)
Table 132. Middle East & Africa On-body Injectors Sales Quantity by Region (2024-2029) & (K Units)
Table 133. Middle East & Africa On-body Injectors Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa On-body Injectors Consumption Value by Region (2024-2029) & (USD Million)
Table 135. On-body Injectors Raw Material
Table 136. Key Manufacturers of On-body Injectors Raw Materials
Table 137. On-body Injectors Typical Distributors
Table 138. On-body Injectors Typical Customers
Table 1. Global On-body Injectors Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global On-body Injectors Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. West Pharmaceutical Services Basic Information, Manufacturing Base and Competitors
Table 4. West Pharmaceutical Services Major Business
Table 5. West Pharmaceutical Services On-body Injectors Product and Services
Table 6. West Pharmaceutical Services On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. West Pharmaceutical Services Recent Developments/Updates
Table 8. Insulet Basic Information, Manufacturing Base and Competitors
Table 9. Insulet Major Business
Table 10. Insulet On-body Injectors Product and Services
Table 11. Insulet On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Insulet Recent Developments/Updates
Table 13. Gerresheimer Basic Information, Manufacturing Base and Competitors
Table 14. Gerresheimer Major Business
Table 15. Gerresheimer On-body Injectors Product and Services
Table 16. Gerresheimer On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Gerresheimer Recent Developments/Updates
Table 18. United Therapeutics Basic Information, Manufacturing Base and Competitors
Table 19. United Therapeutics Major Business
Table 20. United Therapeutics On-body Injectors Product and Services
Table 21. United Therapeutics On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. United Therapeutics Recent Developments/Updates
Table 23. CC Bio Basic Information, Manufacturing Base and Competitors
Table 24. CC Bio Major Business
Table 25. CC Bio On-body Injectors Product and Services
Table 26. CC Bio On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. CC Bio Recent Developments/Updates
Table 28. BD Basic Information, Manufacturing Base and Competitors
Table 29. BD Major Business
Table 30. BD On-body Injectors Product and Services
Table 31. BD On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. BD Recent Developments/Updates
Table 33. Ypsomed Basic Information, Manufacturing Base and Competitors
Table 34. Ypsomed Major Business
Table 35. Ypsomed On-body Injectors Product and Services
Table 36. Ypsomed On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Ypsomed Recent Developments/Updates
Table 38. Enable Injections Basic Information, Manufacturing Base and Competitors
Table 39. Enable Injections Major Business
Table 40. Enable Injections On-body Injectors Product and Services
Table 41. Enable Injections On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Enable Injections Recent Developments/Updates
Table 43. Nemera Basic Information, Manufacturing Base and Competitors
Table 44. Nemera Major Business
Table 45. Nemera On-body Injectors Product and Services
Table 46. Nemera On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Nemera Recent Developments/Updates
Table 48. Stevanato Group Basic Information, Manufacturing Base and Competitors
Table 49. Stevanato Group Major Business
Table 50. Stevanato Group On-body Injectors Product and Services
Table 51. Stevanato Group On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Stevanato Group Recent Developments/Updates
Table 53. Sonceboz Basic Information, Manufacturing Base and Competitors
Table 54. Sonceboz Major Business
Table 55. Sonceboz On-body Injectors Product and Services
Table 56. Sonceboz On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Sonceboz Recent Developments/Updates
Table 58. Lohmann Therapie-Systeme Basic Information, Manufacturing Base and Competitors
Table 59. Lohmann Therapie-Systeme Major Business
Table 60. Lohmann Therapie-Systeme On-body Injectors Product and Services
Table 61. Lohmann Therapie-Systeme On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Lohmann Therapie-Systeme Recent Developments/Updates
Table 63. Elcam Drug Delivery Devices (E3D) Basic Information, Manufacturing Base and Competitors
Table 64. Elcam Drug Delivery Devices (E3D) Major Business
Table 65. Elcam Drug Delivery Devices (E3D) On-body Injectors Product and Services
Table 66. Elcam Drug Delivery Devices (E3D) On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Elcam Drug Delivery Devices (E3D) Recent Developments/Updates
Table 68. Global On-body Injectors Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 69. Global On-body Injectors Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global On-body Injectors Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 71. Market Position of Manufacturers in On-body Injectors, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and On-body Injectors Production Site of Key Manufacturer
Table 73. On-body Injectors Market: Company Product Type Footprint
Table 74. On-body Injectors Market: Company Product Application Footprint
Table 75. On-body Injectors New Market Entrants and Barriers to Market Entry
Table 76. On-body Injectors Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global On-body Injectors Sales Quantity by Region (2018-2023) & (K Units)
Table 78. Global On-body Injectors Sales Quantity by Region (2024-2029) & (K Units)
Table 79. Global On-body Injectors Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global On-body Injectors Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global On-body Injectors Average Price by Region (2018-2023) & (US$/Unit)
Table 82. Global On-body Injectors Average Price by Region (2024-2029) & (US$/Unit)
Table 83. Global On-body Injectors Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Global On-body Injectors Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Global On-body Injectors Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global On-body Injectors Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global On-body Injectors Average Price by Type (2018-2023) & (US$/Unit)
Table 88. Global On-body Injectors Average Price by Type (2024-2029) & (US$/Unit)
Table 89. Global On-body Injectors Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Global On-body Injectors Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Global On-body Injectors Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global On-body Injectors Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global On-body Injectors Average Price by Application (2018-2023) & (US$/Unit)
Table 94. Global On-body Injectors Average Price by Application (2024-2029) & (US$/Unit)
Table 95. North America On-body Injectors Sales Quantity by Type (2018-2023) & (K Units)
Table 96. North America On-body Injectors Sales Quantity by Type (2024-2029) & (K Units)
Table 97. North America On-body Injectors Sales Quantity by Application (2018-2023) & (K Units)
Table 98. North America On-body Injectors Sales Quantity by Application (2024-2029) & (K Units)
Table 99. North America On-body Injectors Sales Quantity by Country (2018-2023) & (K Units)
Table 100. North America On-body Injectors Sales Quantity by Country (2024-2029) & (K Units)
Table 101. North America On-body Injectors Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America On-body Injectors Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe On-body Injectors Sales Quantity by Type (2018-2023) & (K Units)
Table 104. Europe On-body Injectors Sales Quantity by Type (2024-2029) & (K Units)
Table 105. Europe On-body Injectors Sales Quantity by Application (2018-2023) & (K Units)
Table 106. Europe On-body Injectors Sales Quantity by Application (2024-2029) & (K Units)
Table 107. Europe On-body Injectors Sales Quantity by Country (2018-2023) & (K Units)
Table 108. Europe On-body Injectors Sales Quantity by Country (2024-2029) & (K Units)
Table 109. Europe On-body Injectors Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe On-body Injectors Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific On-body Injectors Sales Quantity by Type (2018-2023) & (K Units)
Table 112. Asia-Pacific On-body Injectors Sales Quantity by Type (2024-2029) & (K Units)
Table 113. Asia-Pacific On-body Injectors Sales Quantity by Application (2018-2023) & (K Units)
Table 114. Asia-Pacific On-body Injectors Sales Quantity by Application (2024-2029) & (K Units)
Table 115. Asia-Pacific On-body Injectors Sales Quantity by Region (2018-2023) & (K Units)
Table 116. Asia-Pacific On-body Injectors Sales Quantity by Region (2024-2029) & (K Units)
Table 117. Asia-Pacific On-body Injectors Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific On-body Injectors Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America On-body Injectors Sales Quantity by Type (2018-2023) & (K Units)
Table 120. South America On-body Injectors Sales Quantity by Type (2024-2029) & (K Units)
Table 121. South America On-body Injectors Sales Quantity by Application (2018-2023) & (K Units)
Table 122. South America On-body Injectors Sales Quantity by Application (2024-2029) & (K Units)
Table 123. South America On-body Injectors Sales Quantity by Country (2018-2023) & (K Units)
Table 124. South America On-body Injectors Sales Quantity by Country (2024-2029) & (K Units)
Table 125. South America On-body Injectors Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America On-body Injectors Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa On-body Injectors Sales Quantity by Type (2018-2023) & (K Units)
Table 128. Middle East & Africa On-body Injectors Sales Quantity by Type (2024-2029) & (K Units)
Table 129. Middle East & Africa On-body Injectors Sales Quantity by Application (2018-2023) & (K Units)
Table 130. Middle East & Africa On-body Injectors Sales Quantity by Application (2024-2029) & (K Units)
Table 131. Middle East & Africa On-body Injectors Sales Quantity by Region (2018-2023) & (K Units)
Table 132. Middle East & Africa On-body Injectors Sales Quantity by Region (2024-2029) & (K Units)
Table 133. Middle East & Africa On-body Injectors Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa On-body Injectors Consumption Value by Region (2024-2029) & (USD Million)
Table 135. On-body Injectors Raw Material
Table 136. Key Manufacturers of On-body Injectors Raw Materials
Table 137. On-body Injectors Typical Distributors
Table 138. On-body Injectors Typical Customers
LIST OF FIGURES
Figure 1. On-body Injectors Picture
Figure 2. Global On-body Injectors Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global On-body Injectors Consumption Value Market Share by Type in 2022
Figure 4. Electronic Injectors Examples
Figure 5. Mechanical Injectors Examples
Figure 6. Global On-body Injectors Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global On-body Injectors Consumption Value Market Share by Application in 2022
Figure 8. Immuno-oncology Examples
Figure 9. Cardiovascular Diseases Examples
Figure 10. Neurological Diseases Examples
Figure 11. Others Examples
Figure 12. Global On-body Injectors Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global On-body Injectors Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global On-body Injectors Sales Quantity (2018-2029) & (K Units)
Figure 15. Global On-body Injectors Average Price (2018-2029) & (US$/Unit)
Figure 16. Global On-body Injectors Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global On-body Injectors Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of On-body Injectors by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 On-body Injectors Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 On-body Injectors Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global On-body Injectors Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global On-body Injectors Consumption Value Market Share by Region (2018-2029)
Figure 23. North America On-body Injectors Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe On-body Injectors Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific On-body Injectors Consumption Value (2018-2029) & (USD Million)
Figure 26. South America On-body Injectors Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa On-body Injectors Consumption Value (2018-2029) & (USD Million)
Figure 28. Global On-body Injectors Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global On-body Injectors Consumption Value Market Share by Type (2018-2029)
Figure 30. Global On-body Injectors Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global On-body Injectors Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global On-body Injectors Consumption Value Market Share by Application (2018-2029)
Figure 33. Global On-body Injectors Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America On-body Injectors Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America On-body Injectors Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America On-body Injectors Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America On-body Injectors Consumption Value Market Share by Country (2018-2029)
Figure 38. United States On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe On-body Injectors Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe On-body Injectors Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe On-body Injectors Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe On-body Injectors Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific On-body Injectors Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific On-body Injectors Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific On-body Injectors Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific On-body Injectors Consumption Value Market Share by Region (2018-2029)
Figure 54. China On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America On-body Injectors Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America On-body Injectors Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America On-body Injectors Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America On-body Injectors Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa On-body Injectors Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa On-body Injectors Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa On-body Injectors Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa On-body Injectors Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. On-body Injectors Market Drivers
Figure 75. On-body Injectors Market Restraints
Figure 76. On-body Injectors Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of On-body Injectors in 2022
Figure 79. Manufacturing Process Analysis of On-body Injectors
Figure 80. On-body Injectors Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. On-body Injectors Picture
Figure 2. Global On-body Injectors Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global On-body Injectors Consumption Value Market Share by Type in 2022
Figure 4. Electronic Injectors Examples
Figure 5. Mechanical Injectors Examples
Figure 6. Global On-body Injectors Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global On-body Injectors Consumption Value Market Share by Application in 2022
Figure 8. Immuno-oncology Examples
Figure 9. Cardiovascular Diseases Examples
Figure 10. Neurological Diseases Examples
Figure 11. Others Examples
Figure 12. Global On-body Injectors Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global On-body Injectors Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global On-body Injectors Sales Quantity (2018-2029) & (K Units)
Figure 15. Global On-body Injectors Average Price (2018-2029) & (US$/Unit)
Figure 16. Global On-body Injectors Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global On-body Injectors Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of On-body Injectors by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 On-body Injectors Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 On-body Injectors Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global On-body Injectors Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global On-body Injectors Consumption Value Market Share by Region (2018-2029)
Figure 23. North America On-body Injectors Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe On-body Injectors Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific On-body Injectors Consumption Value (2018-2029) & (USD Million)
Figure 26. South America On-body Injectors Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa On-body Injectors Consumption Value (2018-2029) & (USD Million)
Figure 28. Global On-body Injectors Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global On-body Injectors Consumption Value Market Share by Type (2018-2029)
Figure 30. Global On-body Injectors Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global On-body Injectors Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global On-body Injectors Consumption Value Market Share by Application (2018-2029)
Figure 33. Global On-body Injectors Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America On-body Injectors Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America On-body Injectors Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America On-body Injectors Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America On-body Injectors Consumption Value Market Share by Country (2018-2029)
Figure 38. United States On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe On-body Injectors Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe On-body Injectors Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe On-body Injectors Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe On-body Injectors Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific On-body Injectors Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific On-body Injectors Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific On-body Injectors Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific On-body Injectors Consumption Value Market Share by Region (2018-2029)
Figure 54. China On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America On-body Injectors Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America On-body Injectors Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America On-body Injectors Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America On-body Injectors Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa On-body Injectors Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa On-body Injectors Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa On-body Injectors Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa On-body Injectors Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. On-body Injectors Market Drivers
Figure 75. On-body Injectors Market Restraints
Figure 76. On-body Injectors Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of On-body Injectors in 2022
Figure 79. Manufacturing Process Analysis of On-body Injectors
Figure 80. On-body Injectors Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
